Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11471627 Flow therapy system and method

Patent 11471627 was granted and assigned to Fisher & Paykel Healthcare on October, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Fisher & Paykel Healthcare

Current Assignee

Fisher & Paykel Healthcare

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

October 18, 2022

Patent Application Number

16500329

Date Filed

April 5, 2018

Patent Citations

US Patent 10973466 System for determining airway patency

US Patent 10588518 Congenital heart disease monitor

US Patent 10918341 Physiological parameter system

US Patent 10987066 System for displaying oxygen state indications

Patent Citations Received

US Patent 11921011 Monitoring system for detecting leakages during ventilation, and method

0

Patent Primary Examiner

Margaret M Luarca

CPC Code

A method of determining a duration of safe apnoea. Information is obtained relating to a respiratory indicator, and a duration of safe apnoea is determined from the obtained information. A respiratory therapy system has one or more patient interfaces. A processor is configured to determine a duration of safe apnoea based on obtained information relating to a respiratory indicator.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11471627 Flow therapy system and method

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool